Ascend Wellness Holdings, Inc.
AAWH · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.16 | -0.02 | -0.05 | 0.03 |
| FCF Yield | 7.67% | 18.74% | 8.28% | 33.67% |
| EV / EBITDA | -245.38 | 32.07 | 28.69 | 24.30 |
| Quality | ||||
| ROIC | -0.01% | -0.23% | 0.68% | 2.04% |
| Gross Margin | 34.96% | 32.51% | 30.91% | 34.46% |
| Cash Conversion Ratio | 0.08 | -0.73 | -0.31 | -2.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.70% | 4.99% | 7.95% | 11.43% |
| Free Cash Flow Growth | -7.74% | 94.61% | -78.71% | 395.15% |
| Safety | ||||
| Net Debt / EBITDA | -140.45 | 28.58 | 25.13 | 20.81 |
| Interest Coverage | 0.11 | -0.08 | 0.22 | 0.52 |
| Efficiency | ||||
| Inventory Turnover | 0.98 | 1.04 | 1.03 | 1.00 |
| Cash Conversion Cycle | 112.53 | 91.09 | 90.23 | 93.76 |